Helen Sabzevari - 23 Aug 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Reporting relationship: President and CEO
Issuer ticker: PGEN
Reported as of: 23 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Aug 2026, 17:24:22 UTC
Prior SEC filing: 01 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact

Key filing fact

Helen Sabzevari filed Form 4 for PRECIGEN, INC. (PGEN) on 25 Aug 2026.

Key facts

This page summarizes Helen Sabzevari's Form 4 filing for PRECIGEN, INC. (PGEN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Aug 2026, 17:24.

Change

Previous filing in this sequence was filed on 01 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001724195 Primary reporting owner

Sabzevari Helen

Relationship: President and CEO
Address: 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
Signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Signature date: 25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGEN transaction

Common Stock

Options Exercise

Transaction value
Shares: +20,833
Change %: +0.55%
Price
Shares after: 3,789,705
Date: 23 Aug 2026
Ownership: Direct
Footnotes: F1

PGEN transaction

Common Stock

Tax liability

Transaction value
Shares: -10,184
Change %: -0.27%
Price: $7.20^*
Shares after: 3,779,521
Date: 23 Aug 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGEN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -20,833
Change %: -8.3%
Price: $0.000000^*
Shares after: 229,167
Date: 23 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,833
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

Footnote F2

Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.

Footnote F3

Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.